122 related articles for article (PubMed ID: 16353616)
21. A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.
Lustig RH; Greenway F; Velasquez-Mieyer P; Heimburger D; Schumacher D; Smith D; Smith W; Soler N; Warsi G; Berg W; Maloney J; Benedetto J; Zhu W; Hohneker J
Int J Obes (Lond); 2006 Feb; 30(2):331-41. PubMed ID: 16158082
[TBL] [Abstract][Full Text] [Related]
22. Relationship of para- and perirenal fat and epicardial fat with metabolic parameters in overweight and obese subjects.
Manno C; Campobasso N; Nardecchia A; Triggiani V; Zupo R; Gesualdo L; Silvestris F; De Pergola G
Eat Weight Disord; 2019 Feb; 24(1):67-72. PubMed ID: 29956099
[TBL] [Abstract][Full Text] [Related]
23. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.
Tong PC; Lee ZS; Sea MM; Chow CC; Ko GT; Chan WB; So WY; Ma RC; Ozaki R; Woo J; Cockram CS; Chan JC
Arch Intern Med; 2002 Nov; 162(21):2428-35. PubMed ID: 12437401
[TBL] [Abstract][Full Text] [Related]
24. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
Holte J; Bergh T; Berne C; Lithell H
Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
[TBL] [Abstract][Full Text] [Related]
25. Reduction of abdominal fat and chronic disease factors by lifestyle change in migrant Asian Indians older than 50 years.
Rush EC; Chandu V; Plank LD
Asia Pac J Clin Nutr; 2007; 16(4):671-6. PubMed ID: 18042527
[TBL] [Abstract][Full Text] [Related]
26. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study.
Leão LM; Duarte MP; Silva DM; Bahia PR; Coeli CM; de Farias ML
Eur J Endocrinol; 2006 Jan; 154(1):131-9. PubMed ID: 16382002
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular risk factors in obese children in relation to weight and body fat distribution.
Zwiauer KF; Pakosta R; Mueller T; Widhalm K
J Am Coll Nutr; 1992 Jun; 11 Suppl():41S-50S. PubMed ID: 1619199
[TBL] [Abstract][Full Text] [Related]
28. [Influence of orlistat therapy on serum insulin level and morphological and functional parameters of peripheral arterial circulation in obese patients].
Hajduković Z; Jovelić A; Zivotić-Vanović M; Raden S
Vojnosanit Pregl; 2005 Nov; 62(11):803-10. PubMed ID: 16375203
[TBL] [Abstract][Full Text] [Related]
29. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations.
Major GC; Alarie F; Doré J; Phouttama S; Tremblay A
Am J Clin Nutr; 2007 Jan; 85(1):54-9. PubMed ID: 17209177
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk profile in 38-year and 18-year-old men. Contribution of body fat content and regional fat distribution.
Bonora E; Targher G; Branzi P; Zenere M; Saggiani F; Zenti MG; Travia D; Tonoli M; Muggeo M; Cigolini M
Int J Obes Relat Metab Disord; 1996 Jan; 20(1):28-36. PubMed ID: 8788319
[TBL] [Abstract][Full Text] [Related]
31. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
32. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
[TBL] [Abstract][Full Text] [Related]
33. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.
Davidson MH; Hauptman J; DiGirolamo M; Foreyt JP; Halsted CH; Heber D; Heimburger DC; Lucas CP; Robbins DC; Chung J; Heymsfield SB
JAMA; 1999 Jan; 281(3):235-42. PubMed ID: 9918478
[TBL] [Abstract][Full Text] [Related]
34. Associations of fasting blood glucose with cholesterol absorption and synthesis in nondiabetic middle-aged men.
Stranberg TE; Salomaa V; Vanhanen H; Miettinen TA
Diabetes; 1996 Jun; 45(6):755-61. PubMed ID: 8635649
[TBL] [Abstract][Full Text] [Related]
35. Anthocyanin Rich-Black Soybean Testa Improved Visceral Fat and Plasma Lipid Profiles in Overweight/Obese Korean Adults: A Randomized Controlled Trial.
Lee M; Sorn SR; Park Y; Park HK
J Med Food; 2016 Nov; 19(11):995-1003. PubMed ID: 27809637
[TBL] [Abstract][Full Text] [Related]
36. Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet.
Derosa G; Mugellini A; Ciccarelli L; Fogari R
Clin Ther; 2003 Apr; 25(4):1107-22. PubMed ID: 12809960
[TBL] [Abstract][Full Text] [Related]
37. Impact of weight loss on adipocytokines, C-reactive protein and insulin sensitivity in hypertensive women with central obesity.
Borges RL; Ribeiro-Filho FF; Carvalho KM; Zanella MT
Arq Bras Cardiol; 2007 Dec; 89(6):409-14. PubMed ID: 18317625
[TBL] [Abstract][Full Text] [Related]
38. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.
Faria AN; Ribeiro Filho FF; Kohlmann NE; Gouvea Ferreira SR; Zanella MT
Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141
[TBL] [Abstract][Full Text] [Related]
39. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.
Kwak JH; Ahn CW; Park SH; Jung SU; Min BJ; Kim OY; Lee JH
Food Funct; 2012 Oct; 3(10):1019-24. PubMed ID: 22739624
[TBL] [Abstract][Full Text] [Related]
40. Reduction of body fat and improved lipid profile associated with daily consumption of a Puer tea extract in a hyperlipidemic population: a randomized placebo-controlled trial.
Jensen GS; Beaman JL; He Y; Guo Z; Sun H
Clin Interv Aging; 2016; 11():367-76. PubMed ID: 27069360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
